Onxeo SA (Germany) Profile

1.18
EUR 0.01  1.09%
57%
0%

Onxeo SA Summary

Onxeo SA (C4X) is traded on Frankfurt Stock Exchange in Germany. It is located in 49, Boulevard du g?n?ral Martial Valin and employs 43 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 58.22 M. Onxeo SA has 50.54 M outstanding shares. BIOALLIANCE PHARM has accumulated about 14.28 M in cash with (28.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Onxeo SA Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 1.18HorizonTargetOdds Above 1.18
80.11%30 days 1.18 19.85%
Based on normal probability distribution, the odds of Onxeo SA to move above current price in 30 days from now is about 19.85% (This Onxeo SA probability density function shows the probability of Onxeo SA Stock to fall within a particular range of prices over 30 days) .

Onxeo SA Risk Profiles

Key Fundamentals

Onxeo SA Against Markets

Current Ratings

Onxeo SA 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
76 
Equity ratings for Onxeo SA are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Onxeo SA, a biotechnology company, develops drugs for the treatment of orphan oncology diseases worldwide. The company was formerly known as BioAlliance Pharma SA and changed its name to Onxeo SA in July 2014. Onxeo SA operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 43 people. more
NameOnxeo SA
CEOJudith GrecietView All
Macroaxis Advice
InstrumentGermany Stock View All
Business Address49, Boulevard du g?n?ral Martial Valin
ExchangeFrankfurt Stock Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.onxeo.com
Phone33 1 45 58 76 00
CurrencyEUR - Euro

Onxeo SA Corporate Directors

Elisabeth Carstensen Director of Alliance Management, Member of the Executive Committee
Caroline Lemarchand Preclinical R&D Director, Member of the Executive Committee, Ph.D
Aude Michel Director of Legal Affairs, Agreements and Licensing, Member of the Executive Committee
Check also Trending Equities. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.